Wendy Mcdermott
Personalreferent bei LEXICON PHARMACEUTICALS, INC.
Vermögen: 81 149 $ am 30.04.2024
Profil
Wendy E.
Mcdermott is currently the Vice President-Human Resources at Lexicon Pharmaceuticals, Inc. She previously worked as the Vice President-Human Resources at Sanofi Corp.
from 2017 to 2019 and as the Chief People Officer at Cornerstone Pharmaceuticals, Inc. She obtained an undergraduate degree from the State University of New York College at Plattsburgh.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.02.2024 | 52 694 ( 0,02% ) | 81 149 $ | 30.04.2024 |
Aktive Positionen von Wendy Mcdermott
| Unternehmen | Position | Beginn |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Personalreferent | 01.01.2022 |
Ehemalige bekannte Positionen von Wendy Mcdermott
| Unternehmen | Position | Ende |
|---|---|---|
| Sanofi Corp. | Personalreferent | 01.01.2019 |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Personalreferent | - |
Ausbildung von Wendy Mcdermott
| State University of New York College at Plattsburgh | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
| Sanofi Corp. |
